Chemokines: a new classification system and their role in immunity.

By A. Zlotnik, O. Yoshie. Immunity, 2000

4,209 citations recorded by the source corpus.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/8bf3c42d6d1535dcdd83618880f575c9c2d88440

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. U. V. von Andrian
2. J. Van Damme
3. F. Aloisi
4. A. Zlotnik
5. O. Yoshie
6. A. Rot
7. T. Gajewski
8. J. Benovic

In Oncology

1. Christopher M. Overall
2. U. V. von Andrian
3. J. Van Damme
4. F. Aloisi
5. A. Zlotnik
6. O. Yoshie
7. A. Rot
8. T. Gajewski

Citations in the corpus

• Macrophage inflammatory protein-1. (2002, background): “The receptor was designated CC-CKR1, but recently, it has been renamed CCR1 to fit with the new nomenclature [23].”
• Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells (2001, background): “Chemokines are small chemotactic cytokines characterized by critically positioned cysteine residues, which recruit distinct leukocyte subsets to sites of inflammation and specific microenvironments within secondary lymphoid tissues (1, 2).”
• Chemokines and chemokine receptors in leukocyte trafficking. (2002, background): “Human chemokines for which a mouse homolog has not yet been discovered include IL-8, neutrophil-activating protein-2 (NAP-2), I-TAC, MCP-4, hemofiltrate CC chemokine-1 (HCC-1), myeloid progenitor inhibitory factor-1 (MPIF-1) and -2, and eotaxin-2 and -3, whereas mouse chemokines with no human counte”
• Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. (2001, methodology): “tients were receiving a standard peritoneal dialysis therapy of four presented in parentheses, in accordance with the recently proposed chemokine classification system (Zlotnik and Yoshie, 2000).”
• An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4 (2003, background): “The chemokines CXCL9, CXCL10, and CXCL11 exhibit several activities, including the induction of proliferation of HMC (22, 23) and the inhibition of endothelial cell growth (4–10).”
• The role of CXC chemokines and their receptors in cancer. (2008, background): “[3] A.”
• Of Mice and Not Men: Differences between Mouse and Human Immunology (2004, background): “Conversely, CCL6, CCL9, lungkine (CXCL15), and MCP-5 (CCL12) have been identified in mice but not humans (66, 67).”